COVID-19 и сердечно-сосудистая система. Часть II. Постковидный синдром
https://doi.org/10.23934/2223-9022-2021-10-2-248-258
Аннотация
Долгосрочный прогноз состояния пациентов, перенесших COVID-19, остается до конца не изученным. Рассмотрены данные о распространенности постковидного синдрома (ПКС), основных симптомах, особенностях течения, а также механизмах его развития и связь с коморбидностью. Поражение легких, сердца, мозга и других систем требует мультидисциплинарного ведения пациентов с ПКС.
Об авторах
А. А. Иванников
ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ», Учебный центр
Россия
Россия
клинический ординатор по специальности «кардиология»,
129090, Москва, Б. Сухаревская пл., д. 3
А. Н. Эсауленко
ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ», Учебный центр
Россия
Россия
клинический ординатор по специальности «кардиология»,
129090, Москва, Б. Сухаревская пл., д. 3
М. К. Васильченко
ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ», Учебный центр
Россия
Россия
клинический ординатор по специальности «кардиология»,
129090, Москва, Б. Сухаревская пл., д. 3
Х. Г. Алиджанова
ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ», Учебный центр
Россия
Россия
доктор медицинских наук, старший преподаватель учебного центра,
129090, Москва, Б. Сухаревская пл., д. 3
С. С. Петриков
ГБУЗ «Научно-исследовательский институт скорой помощи им. Н.В. Склифосовского ДЗМ», Учебный центр
Россия
Россия
член-корреспондент РАН, доктор медицинских наук, директор,
129090, Москва, Б. Сухаревская пл., д. 3
Список литературы
1. NIHR Themed Review: Living with Covid19. October 2020. Available at: https://evidence.nihr.ac.uk/themedreview/living-with-covid19/ [Accessed April 08, 2021] https://doi.org/10.3310/themedreview_41169
2. O’Sullivan O. Long-term sequelae following previous coronavirus epidemics. Clin Med (Lond). 2021;21(1):e68–e70. PMID: 33144403 https://doi.org/10.7861/clinmed.2020-0204
3. Ahmed H, Patel K, Greenwood DC, Halpin S, Lewthwaite P, Salawu A, et al. Long-term clinical outcomes in survivors of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) coronavirus outbreaks after hospitalisation or ICU admission: a systematic review and meta-analysis. J Rehabil Med. 2020;52(5): jrm00063. PMID: 32449782 https://doi.org/10.2340/16501977-2694
4. Iqbal A, Iqbal K, Arshad Ali S, Azim D, Farid E, Baig MD, et al. The COVID-19 Sequelae: A Cross-Sectional Evaluation of Post-recovery Symptoms and the Need for Rehabilitation of COVID-19 Survivors. Cureus. 2021;13(2):e13080. PMID: 33680620 https://doi.org/10.7759/cureus.13080
5. Raveendran AV. Long COVID-19: Challenges in the diagnosis and proposed diagnostic criteria. Diabetes Metab Syndr. 2021;15(1):145– 146. PMID: 33341598 https://doi.org/10.1016/j.dsx.2020.12.025
6. Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. Cardiopulmonary recovery after COVID-19 – an observational prospective multi-center trial. Eur Respir J. 2020 Dec 10:2003481. PMID: 33303539 https://doi.org/10.1183/13993003.03481-2020 Online ahead of print
7. Moreno-Pérez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jiménez J, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect. 2021;82(3):378–383. PMID: 33450302 https://doi.org/10.1016/j.jinf.2021.01.004
8. Carfì A, Bernabei R, Landi F, Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent symptoms in patients after acute Covid-19. JAMA. 2020;324(6):603–605. PMID: 32644129 https://doi.org/10.1001/jama.2020.12603
9. Oronsky B, Larson C, Hammond TC, Oronsky A, Kesari S, Lybeck M, et al. A Review of Persistent Post-COVID Syndrome (PPCS). Clin Rev Allergy Immunol. 2021 Feb 20:1–9. PMID: 33609255 https://doi.org/10.1007/ s12016-021-08848-3 Online ahead of print.
10. Wang F, Kream RM, Stefano GB. Long-term respiratory and neurological sequelae of COVID-19. Med Sci Monit. 2020;26:e928996. PMID: 33177481 https://doi.org/10.12659/MSM.928996
11. Mendelson M, Nel J, Blumberg L, Madhi SA, Dryden M, Stevens W, et al. Long-COVID: An evolving problem with an extensive impact. S Afr Med J. 2020;111(1):10–12. PMID: 33403997 https://doi.org/10.7196/ SAMJ.2020.v111i11.15433
12. Venkatesan P. NICE guideline on long COVID. Lancet Respir Med. 2021;9(2):129. PMID: 33453162 https://doi.org/10.1016/S2213-2600(21)00031-X
13. Mahase E. Long covid could be four different syndromes, review suggests. BMJ. 2020;371:m3981. PMID: 33055076 https://doi.org/10.1136/bmj. m3981 14. Garg P, Arora U, Kumar A, Wig N. The “post-COVID” syndrome: how deep is the damage? J Med Virol. 2021;93(2):673–674. PMID: 32852801 https://doi.org/10.1002/jmv.26465
14. Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. Management of post-acute Covid-19 in primary care. BMJ. 2020;370:m3026. PMID: 32784198 https://doi.org/10.1136/bmj.m3026
15. Willi S, Lüthold R, Hunt A, Hänggi NV, Sejdiu D, Scaff C, et al. COVID19 Sequelae in adults aged less than 50 years: A Systematic Review. Travel Med Infect Dis. 2021;40:101995. PMID: 33631340 https://doi.org/10.1016/j.tmaid.2021.101995
16. Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract. 2020 Sep 29:e13746. PMID: 32991035 https://doi.org/10.1111/ijcp.13746 Online ahead of print
17. Zhao YM, Shang YM, Song WB, Li QQ, Xie H, Xu QF, et al. Followup study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. PMID: 32838236 https://doi.org/10.1016/j.eclinm.2020.100463
18. van den Borst B, Peters JB, Brink M, Schoon Y, Bleeker-Rovers CP, Schers H, et al. Comprehensive health assessment three months after recovery from acute COVID-19. Clin Infect Dis. 2020 Nov 21:ciaa1750. PMID: 33220049 https://doi.org/10.1093/cid/ciaa1750 Online ahead of print.
19. Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220–232. PMID: 33428867 https://doi.org/10.1016/S0140-6736(20)32656-8
20. Seeherman S, Suzuki YJ. Suzuki Viral Infection and Cardiovascular Disease: Implications for the Molecular Basis of COVID-19 Pathogenesis. Int J Mol Sci. 2021;22(4):1659. PMID: 33562193 https://doi.org/10.3390/ijms22041659
21. Simmonds P, Williams S, Harvala H. Understanding the outcomes of COVID-19–does the current model of an acute respiratory infection really fit? J Gen Virol. 2021;102(3). PMID: 33331810 https://doi.org/10.1099/jgv.0.001545
22. Biradar V, Moran JL. SIRS, Sepsis and Multiorgan Failure. In: Fitridge R, Thompson M, (eds). Mechanisms of vascular disease: a reference book for vascular specialists. Adelaide (AU): Barr Smith Press; 2011. p. 315–330.
23. Walton AH, Muenzer JT, Rasche D, Boomer JS, Sato B, Brownstein BH, et al Reactivation of multiple viruses in patients with sepsis. PLoS One. 2014;9(2):e98819. PMID: 24919177 https://doi.org/10.1371/journal.pone.0098819 eCollection 2014.
24. Liu W-D, Chang S-Y, Wang J-T, Tsai M-J, Hung C-C, Hsu CL, et al. Prolonged virus shedding even after seroconversion in a patient with COVID-19. J Infect. 2020;81(2):318–356.PMID: 32283147 https://doi.org/10.1016/j.jinf.2020.03.063
25. Zhang L, Li C, Zhou Y, Wang B, Zhang J. Persistent viral shedding lasting over 60 days in a mild COVID-19 patient with ongoing positive SARS-CoV-2. Quant Imaging Med Surg. 2020;10(5):1141–1144. PMID: 32489935 https://doi.org/10.21037/qims.2020.04.08
26. Molina LP, Chow SK, Nickel A, Love JE. Prolonged detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in an obstetric patient with antibody seroconversion. Obstet Gynecol. 2020;136(4):838–841. PMID: 32701763 https://doi.org/10.1097/AOG.0000000000004086
27. Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S, et al. Management of COVID-19: the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020;49(2):147–157. PMID: 32391658 https://doi.org/10.3785/j.issn.1008-9292.2020.02.02
28. Yong SJ. Persistent Brainstem Dysfunction in Long-COVID: A Hypothesis. ACS Chem Neurosci. 2021;12(4):573–580. PMID: 33538586 https://doi.org/10.1021/acschemneuro.0c00793
29. Steyers CM 3rd, Miller FJ Jr. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349. PMID: 24968272 https://doi.org/10.3390/ijms150711324
30. Malyszko J. Mechanism of endothelial dysfunction in chronic kidney disease. Clin Chim Acta. 2010;411(19–20):1412–1420. PMID: 20598675 https://doi.org/10.1016/j.cca.2010.06.019
31. Bermejo-Martin JF, Almansa R, Torres A, González-Rivera M, Kelvin DJ. COVID-19 as a cardiovascular disease: the potential role of chronic endothelial dysfunction. Cardiovasc Res. 2020;116(10):e132–e133. PMID: 32420587 https://doi.org/10.1093/cvr/cvaa140
32. Poredos P, Jezovnik MK. Endothelial dysfunction and venous thrombosis. Angiology. 2018;69(7):564–567. PMID: 28954526 https://doi.org/10.1177/0003319717732238
33. Kang S, Narazaki M, Metwally H, Kishimoto T. Historical overview of the interleukin-6 family cytokine. J Exp Med. 2020;217(5):e20190347. PMID: 32267936 https://doi.org/10.1084/jem.20190347
34. Minciullo PL, Catalano A, Mandraffino G, Casciaro M, Crucitti A, Maltese G, Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch Immunol Ther Exp (Warsz). 2016;64(2):111– 126. PMID: 26658771 https://doi.org/10.1007/s00005-015-0377-3
35. Reiss AB, Siegart NM, De Leon J. Interleukin-6 in atherosclerosis: atherogenic or atheroprotective? Clin Lipidology. 2017;12(1):14–23. https://doi.org/10.1080/17584299.2017.1319787
36. Kälsch AI, Scharnagl H, Kleber ME, Windpassinger C, Sattler W, Leipe J, et al. Long- and short-term association of low-grade systemic inflammation with cardiovascular mortality in the LURIC study. Clin Res Cardiol. 2020;109(3):358–373. PMID: 31263995 https://doi.org/10.1007/s00392-019-01516-9
37. Fanola CL, Morrow DA, Cannon CP, Jarolim P, Lukas MA, Bode C, et al. Interleukin-6 and the risk of adverse outcomes in patients after an acute coronary syndrome: observations from the SOLID-TIMI 52 (stabilization of plaque using darapladib — thrombolysis in myocardial infarction 52) trial. J Am Heart Assoc. 2017;6(10):e005637. PMID: 29066436 https://doi.org/10.1161/JAHA.117.005637
38. Gager GM, Biesinger B, Hofer F, Winter MP, Hengstenberg C, Jilma B, et al. Interleukin-6 level is a powerful predictor of long-term cardiovascular mortality in patients with acute coronary syndrome. Vascul Pharmacol. 2020;135:106806. PMID: 33035661 https://doi.org/10.1016/j.vph.2020.106806
39. Coomes EA, Haghbayan H. Interleukin-6 in COVID-19: a systematic review and meta-analysis. Rev Med Virol. 2020;30(6):1–9. PMID: 32845568 https://doi.org/10.1002/rmv.2141
40. Price J, Lord JM, Harrison P. Inflammaging and platelet hyperreactivity: a new therapeutic target. J Thromb Haemost. 2020;18(1):3–5. PMID: 31894663 https://doi.org/10.1111/jth.14670
41. Wassmann S, Nickenig G. The role of the AT1 receptor in the cardiovascular continuum. Eur Heart J Suppl. 2004;6(Suppl_H):h3–h9. https://doi.org/10.1093/eurheartj/6.suppl_h.h3
42. Schmieder RE. Endothelial dysfunction: how can one intervene at the beginning of the cardiovascular continuum? J Hypertens Suppl. 2006;24(2):S31–35. PMID: 16601559 https://doi.org/10.1097/01.hjh.0000220101.57896.cd
43. Benigni A, Cassis P, Remuzzi G. Angiotensin II revisited: new roles in inflammation, immunology and aging. EMBO Mol Med. 2010;2(7):247– 257. PMID: 20597104 https://doi.org/10.1002/emmm.201000080
44. Cheng ZJ, Vapaatalo H, Mervaala E. Angiotensin II and vascular inflammation. Med Sci Monit. 2005;11(6):RA194–205. PMID: 15917731
45. Soro-Paavonen A, Gordin D, Forsblom C, Rosengard-Barlund M, Waden J, Thorn L, et al. Circulating ACE2 activity is increased in patients with type 1 diabetes and vascular complications. J Hypertens. 2012;30(2):375– 383. PMID: 22179088 https://doi.org/10.1097/hjh.0b013e32834f04b6
46. Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, thrombosis, kidney failure, and diabetes: is COVID-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. J Clin Med. 2020;9(5):1417. PMID: 32403217 https://doi.org/10.3390/jcm9051417
47. Amenta EM, Spallone A, Rodriguez-Barradas MC, El Sahly HM, Atmar RL, Kulkarni PA. Postacute COVID-19: An Overview and Approach to Classification. Open Forum Infect Dis. 2020;7(12):ofaa509. PMID: 33403218 https://doi.org/10.1093/ofid/ofaa509
48. Ng WH, Tipih T, Makoah NA, Vermeulen JG, Goedhals D, Sempa JB, et al. Comorbidities in SARS-CoV-2 Patients: a Systematic Review and MetaAnalysis. mBio. 2021;12(1):e03647–20. PMID: 33563817 https://doi.org/10.1128/mBio.03647-20
49. Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long-term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. PMID: 33483331 https://doi.org/10.1136/bmj. n136
50. Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syndrome. Nat Med. 2021 Mar 22. PMID: 33753937 https://doi.org/10.1038/s41591-021-01283-z Online ahead of print.
51. Girard TD, Ware LB, Bernard GR, Pandharipande PP, Thompson JL, Shintani AK, et al. Associations of markers of inflammation and coagulation with delirium during critical illness. Intensive Care Med. 2012;38(12):1965–1973. PMID: 22903241 https://doi.org/10.1007/s00134-012-2678-x
52. Baumgart M, Snyder HM, Carrillo MC, Fazio S, Kim H, Johns H. Summary of the evidence on modifiable risk factors for cognitive decline and dementia: a population-based perspective. Alzheimers Dement. 2015;11(6):718–726. PMID: 26045020 https://doi.org/10.1016/j.jalz.2015.05.016
53. Robertson DA, Savva GM, Kenny RA. Frailty and cognitive impairment— a review of the evidence and causal mechanisms. Ageing Res Rev. 2013;12(4):840–851. PMID: 23831959 https://doi.org/10.1016/j.arr.2013.06.004
54. Nordvig AS, Rimmer KT, Willey JZ, Thakur KT, Boehme AK, Vargas WS, et al. Potential neurological manifestations of COVID-19. Neurol Clin Pract. 2020 June 30. Available at: https://cp.neurology.org/content/early/2020/06/30/CPJ.0000000000000897/ [Accessed April 08, 2021] https://doi.org/10.1212/CPJ.0000000000000897
55. Garrigues E, Janvier P, Kherabi Y, Le Bot A, Hamon A, Gouze H, et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81(6):e4–e6. PMID: 32853602 https://doi.org/10.1016/j.jinf.2020.08.029
56. Junhua M, Zhang Q, Gong X, Li L, Zhang Z, Wang J, et al. Analysis of psychological and sleep state of medical stuff with novel coronavirus pneumonia. Herald Med. 2020;39(3):345–349. https://doi.org/10.3870/j.issn.1004-0781.2020.03.017
57. Geriatric Medicine Research Collaborative. Delirium is prevalent in older hospital inpatients and associated with adverse outcomes: results of a prospective multi-centre study on World Delirium Awareness Day. BMC Med. 2019;17(1):229. PMID: 31837711 https://doi.org/10.1186/s12916-019-1458-7
58. Steardo L, Steardo L, Zorec R, Verkhratsky A. Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID19. Acta Physiol (Oxf). 2020;229(3):e13473. PMID: 32223077 https://doi.org/10.1111/apha.13473
59. Mcloughlin BC, Miles A, Webb TE, Knopp P, Eyres C, Fabbri A, et al. Functional and cognitive outcomes after COVID-19 delirium. Eur Geriatr Med. 2020;11(5):857–862. PMID: 32666303 https://doi.org/10.1007/s41999-020-00353-8
60. Safavynia SA, Arora S, Pryor KO, García PS. An update on postoperative delirium: clinical features, neuropathogenesis, and perioperative management. Curr Anesthesiol Rep. 2018;8(3):252–262. PMID: 30555281
61. Safavynia SA, Goldstein PA. The role of neuroinflammation in postoperative cognitive dysfunction: moving from hypothesis to treatment. Front Psychiatry. 2019;9:752. PMID: 30705643 https://doi.org/10.3389/fpsyt.2018.00752
62. Goërtz YMJ, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado FVC,et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542–2020. PMID: 33257910 https://doi.org/10.1183/23120541.00542-2020
63. Вербовой А.Ф., Цанава И.А., Вербовая Н.И. Медицина XXI века: в фокусе коморбидность. Университетская медицина Урала. 2017;3(2):27–31.
64. Sanyaolu A, Okorie C, Marinkovic A, Patidar R, Younis K, Desai P, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med. 2020 Jun 25:1–8. PMID: 32838147 https://doi.org/10.1007/s42399-020-00363-4 Online ahead of print.
65. Pranata R, Supriyadi R, Huang I, Permana H, Lim MA, Yonas E, et al. The association between chronic kidney disease and new onset renal replacement therapy on the outcome of COVID-19 patients: a metaanalysis. Clin Med Insights Circ Respir Pulm Med. 2020;14:11795484209 59165. PMID: 32994700 https://doi.org/10.1177/1179548420959165
66. Kunutsor SK, Laukkanen JA. Renal complications in COVID-19: a systematic review and meta-analysis. Ann Med. 2020;52(7):345–353. PMID: 32643418 https://doi.org/10.1080/07853890.2020.1790643
67. Муркамилов И.Т., Айтбаев К.А., Фомин В.В., Муркамилова Ж.А., Сабиров И.С., Райимжанов З.Р. и др. Провоспалительные цитокины у больных с хронической болезнью почек: в фокусе Интерлейкин-6. Архивъ внутренней медицины. 2019;(6):428–433. https://doi.org/10.20514/2226-6704-2019-9-6-428-433
68. Fernández-de-Las-Peñas C, Palacios-Ceña D, Gómez-Mayordomo V, Cuadrado ML, Florencio LL. Defining Post-COVID Symptoms (PostAcute COVID, Long COVID, Persistent Post-COVID): An Integrative Classification. Int J Environ Res Public Health. 2021;18(5):2621. PMID: 33807869 https://doi.org/10.3390/ijerph18052621
Рецензия
Для цитирования:
Иванников А.А., Эсауленко А.Н., Васильченко М.К., Алиджанова Х.Г., Петриков С.С. COVID-19 и сердечно-сосудистая система. Часть II. Постковидный синдром. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2021;10(2):248-258. https://doi.org/10.23934/2223-9022-2021-10-2-248-258
For citation:
Ivannikov A.A., Esaulenko A.N., Vasilchenko M.K., Alidzhanova Kh.G., Petrikov S.S. COVID-19 and Cardiovascular System. Part II. Post-COVID Syndrome. Russian Sklifosovsky Journal "Emergency Medical Care". 2021;10(2):248-258. https://doi.org/10.23934/2223-9022-2021-10-2-248-258
Просмотров:
107011
Послать статью по эл. почте 